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Histamine modulation of urinary 
bladder urothelium, lamina propria 
and detrusor contractile activity via 
H1 and H2 receptors
Zane stromberga  , Russ Chess-Williams & Christian Moro  
the mechanisms underlying bladder contractile disorders such as overactive bladder are not fully 
understood, and there is limited understanding of the receptor systems modulating spontaneous 
bladder contractions. We investigated the potential for histamine to have a role in mediating 
contractility of the urothelium with lamina propria (U&LP) or detrusor via the H1-H4 histamine receptor 
subtypes. Isolated strips of porcine U&Lp or detrusor smooth muscle were mounted in gassed Krebs-
bicarbonate solution and responses to histamine obtained in the absence and presence of selective 
receptor antagonists. the presence of histamine increases the frequency of U&Lp spontaneous 
phasic contractions and baseline tensions. In response to histamine, H1-antagonists pyrilamine, 
fexofenadine and cyproheptadine were effective at inhibiting contractile responses. Cimetidine (H2-
antagonist) enhanced increases in baseline tension in response histamine, whereas amthamine (H2-
agonist) induced relaxation. Although thioperamide (H3/H4-antagonist) increased baseline tension 
responses to histamine, selective H1/H2-receptor antagonism revealed no influence of these receptors. 
In detrusor preparations, pyrilamine, fexofenadine and cyproheptadine were effective at inhibiting 
baseline tension increases in response to histamine. Our findings provide evidence that histamine 
produces contractile responses both in the U&LP and detrusor via the H1-receptor, and this response is 
significantly inhibited by activation of the H2-receptor in the U&LP but not the detrusor.
The underlying mechanisms of bladder contractile disorders such as overactive bladder (OAB) are unclear. 
However, it is known that detrusor smooth muscle provides the force for contractions during voiding. In recent 
years, interest has been building on the role of the urothelium and lamina propria (U&LP) in regulating and 
modulating overall bladder contractile activity. Among other functions, U&LP is capable of releasing various 
mediators when activated by chemical or mechanical stimuli such as acetylcholine which can influence detrusor 
contractions1. It is also capable of responding to external stimuli such as noradrenaline2 or nitric oxide3 and can 
release agents such as ATP, which may contribute to overactive bladder4. Research also suggests that U&LP is 
capable of developing spontaneous phasic contractile activity in the absence of any external stimulation, and this 
activity can potentially influence the bladder as a whole1.
Bladder contractions are mainly controlled by the parasympathetic nerves5 which release acetylcholine to 
activate M3 muscarinic receptors on the detrusor smooth muscle6. Antimuscarinic treatment has been used as 
the first-line pharmacology intervention for many years, however, there is a need for alternative treatment options 
due to the large number of side-effects associated with antimuscarinic use7 and the low rates of patient adher-
ence8. One alternative target involved in the pathogenesis of contractile dysfunctions, such as OAB may be the 
inflammatory mediators released from mast cells at sites of inflammation.
Mast cells play an important role in immediate allergic reactions and during inflammation9. Upon activa-
tion, they release and synthesise potent inflammatory mediators including histamine, prostaglandins, proteases, 
cytokines that act on smooth muscle, connective tissue, mucous glands and other inflammatory cells10. In the 
urinary bladder, mast cells can be found in the urothelium, lamina propria and smooth muscle layers of the 
bladder wall11–13 and have previously been associated with the pathogenesis of interstitial cystitis11,14 and OAB15. 
Furthermore, upregulation of chemoattractant protein-1 (MCP-1) which causes degranulation of mast cells has 
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been observed in patients with OAB16. A histological investigation of 179 biopsies obtained from patients with 
OAB found signs of chronic inflammation in 70% of biopsies with inflammatory cells having infiltrated the lam-
ina propria in 98% of biopsies and urothelium in 18%17. Therefore, the involvement of histamine is of great inter-
est as it is the predominant mediator involved in the mechanisms of acute allergy and inflammation.
Histamine exerts its function by binding to four different G protein-coupled receptors, namely H1, H2, H3 
and H418. Both H1 and H2 receptors are co-expressed in most tissues and cell types, including smooth muscle, 
epithelial tissue, neurons and various white blood cells19. Western blot analysis of cultured human detrusor cells 
has revealed the presence of all four histamine receptors subtypes: H1, H2, H3 and H420, although functional roles 
of these receptor subtypes are still not fully understood. There is also evidence that histamine is involved in the 
modulation of bladder contractile activity via the activation of H1 receptors in guinea pig21–23 and rabbit detrusor 
muscle24. It has also been suggested that responses to histamine may stimulate acetylcholine release from sites 
proximal to the muscle25, or influence purinergic neurotransmission on nearby nerves26. This study aims to inves-
tigate the effect of histamine on the contractility of U&LP and detrusor smooth muscle and identify the histamine 
receptor subtypes responsible for mediating contractile responses.
Materials and Methods
tissue preparation. The urinary bladders from Large White-Landrace pigs were acquired from the local 
commercial abattoir after slaughter for the routine commercial provision of food. All methods were carried out 
in accordance with relevant Australian guidelines and regulations, and all experimental protocols were in accord-
ance the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Urinary bladder 
was separated from the urethra and the ureters removed. Isolated strips (10 mm × 5 mm) were removed from the 
anterior wall of the bladder dome region and urothelium with lamina propria dissected from the underlying det-
rusor layer, consistent with past studies1. Adjacent pieces of U&LP and detrusor were suspended in pairs in 10 mL 
organ baths (Labglass, Brisbane, Australia) containing Krebs-bicarbonate solution (NaCl 118.4 mM, NaHCO3 
24.9 mM, CaCl2 1.9 mM, MgSO4 2.41 mM, KCl 4.6 mM, KH2PO4 1.18 mM and D-glucose 11.7 mM) at 37 °C and 
perfused with a gas mixture of 95% oxygen and 5% carbon dioxide. Tissue strips were washed three times and 
tension readjusted to approximately 2 g, where this was maintained as the baseline tension. A single dose of 
agonist was added to the tissue both in the presence and absence of antagonists, and concentrations selective for 
each receptor subtype determined using affinity values appearing in the literature. Tissue strips that were exposed 
to antagonists and tissues treated with vehicle control were incubated for 30 minutes to allow full equilibration 
with the receptor. Baseline tension and the frequency and amplitude of spontaneous phasic contractions were 
recorded simultaneously using isometric force transducers (MCT050/D, ADInstruments, Castle Hill, Australia) 
on a Powerlab system using Labchart v7 software (ADInstruments). Changes in tension were measured in grams, 
frequency was expressed as the number of spontaneous phasic contractions per minute (cycles/min) and ampli-
tude was expressed in grams (lowest point of spontaneous phasic contraction to peak). Data was graphed and 
analysed using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla California USA) and 
results shown as the mean change ± SEM. Responses between control and experimental tissues were compared 
using Student’s t-test with p < 0.05 considered significant.
Histamine agonist effects on baseline tension, amplitude and spontaneous phasic contractions. 
A single dose of histamine (100 µM, Sigma Aldrich, Missouri, USA) or amthamine (100 µM, H2 agonist, Sigma 
Aldrich, Missouri, USA) was applied to the tissue after a 30-minute equilibration period. Baseline tension, ampli-
tude and spontaneous phasic contractions of U&LP were measured before the application of the agonist and 
2 minutes after. The baseline tension for detrusor was measured at the same time-points as used for U&LP.
The effects of histamine on baseline tension, amplitude and spontaneous phasic contractions 
in the presence of histamine receptor antagonists. The H1 receptor antagonists pyrilamine (30 nM, 
Cayman Chemicals, Michigan, USA), fexofenadine (1 µM, Cayman Chemicals, Michigan, USA) and cypro-
heptadine (30 nM, Cayman Chemicals, Michigan, USA), the H2 receptor antagonist cimetidine (1 µM, Sigma 
Aldrich, Missouri, USA) and the dual H3&H4 receptor antagonist thioperamide (1 µM, Sigma Aldrich, Missouri, 
USA) were separately applied to tissues. After 30-minute incubation with antagonists, a single dose of histamine 
(100 µM) was applied to the tissues. In another group of experiments, a combination of antagonists was used. 
Histamine responses to pyrilamine (30 nM) treated tissues were compared with a combination of pyrilamine 
(30 nM) and cimetidine (1 µM) treated tissues; cimetidine (1 µM) treated tissues were compared with a com-
bination of pyrilamine (30 nM) and cimetidine (1 µM) treated tissues; combination of pyrilamine (30 nM) and 
cimetidine (1 µM) treated tissues were compared with a combination of pyrilamine (30 nM), cimetidine (1 µM) 
and thioperamide (1 µM) treated tissues.
Results
Influence of histamine receptor agonists in U&LP and detrusor. In the absence of histamine or 
any antagonists, strips of urothelium/lamina propria (U&LP) developed spontaneous phasic contractions 
at a frequency of 3.56 ± 0.13 cycles per min−1 (cpm) with an amplitude of 0.46 ± 0.03 g (n = 48). When hista-
mine (100 µM) was added to the tissues, U&LP baseline tension increased by 0.98 ± 0.13 g (p < 0.001, n = 48). 
Additionally, frequency of spontaneous phasic contractions increased by 1.32 ± 0.25 cpm (p < 0.001, n = 48) and 
amplitude decreased by 22.9 ± 5.8% (p < 0.001, n = 48) during the peak response to histamine (100 µM). Baseline 
tension, frequency and amplitude of spontaneous phasic contractions in response to histamine was not affected 
by the presence of the muscarinic receptor antagonist atropine (1 µM, Sigma Aldrich, Missouri, USA).
When H2 agonist amthamine (1 μM) was added to strips of U&LP that were left to equilibrate at a ten-
sion of approximately 2 g in the absence of any agonists and antagonists, resting baseline tension decreased 
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by 0.13 ± 0.02 g (p < 0.01, n = 12) 5 minutes after the addition of agonist and by 0.22 ± 0.04 g after 20 minutes 
(p < 0.01, n = 12).
In detrusor preparations, an increase in baseline tension of 0.99 ± 0.27 g (p < 0.001, n = 48) was observed in 
response to histamine (100 µM). The addition of H2 agonist amthamine (1 µM) had no influence on the baseline 
tension in detrusor preparations.
Influence of selective histamine receptor antagonists in U&LP. The responses to histamine were 
observed in the presence of three selective histamine receptor antagonists: pyrilamine, cimetidine and thiop-
eramide. In the presence of pyrilamine (H1 antagonist, 30 nM), increases in the baseline tension and frequency 
of spontaneous phasic contractions in response to histamine (100 µM) were significantly inhibited (n = 8, 
p < 0.05 for both). Histamine (100 µM) in the presence of pyrilamine caused an increase in baseline tension 
by 0.17 ± 0.11 g (Fig. 1) and in the frequency of spontaneous phasic contractions by 0.15 ± 0.25 cpm (Table 1). 
Furthermore, when the alternative H1-selective antagonists fexofenadine (1 µM, n = 8) and cyproheptadine 
(30 nM, n = 8) were added to the U&LP tissue strips, inhibitions to baseline tension and frequency of sponta-
neous phasic contraction increases (Table 1) in response to histamine (100 µM) were also observed (p < 0.01 for 
both).
Cimetidine (H2 antagonist, 1 µM) caused a significant increase of 0.81 ± 0.25 g above the baseline tension in 
response to histamine (100 µM) (n = 8, p < 0.05, Fig. 1) and an increase in the frequency of spontaneous phasic 
contractions of 1.41 ± 0.94 cpm (Table 1). The addition of thioperamide (H3/H4 antagonist, 1 µM) resulted in the 
tissue achieving significantly greater contractions to histamine (100 µM, n = 6) than in control samples, resulting 
in a 1.75 ± 0.29 g increase in tension from baseline tension (p < 0.05), with no influence on the frequency of spon-
taneous contractions (Table 1). None of the antagonists had any influence on the amplitude of phasic spontaneous 
contractions in response to histamine (100 µM).
Figure 1. U&LP responses to histamine (100 µM) as control (left) and in the presence of histamine receptor 
antagonists pyrilamine, cimetidine and thioperamide (right).
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In experiments where combinations of antagonists were used, the ability of cimetidine (1 µM) to enhance 
contraction to histamine (100 µM) was abolished when tissues were also treated with pyrilamine (30 nM, n = 8, 
p < 0.001, Fig. 2). Alternatively, the effectiveness of pyrilamine (30 nM) inhibiting histamine responses (100 µM) 
was equally effective in baths containing a combination of pyrilamine (30 nM) and cimetidine (1 µM, n = 8, 
Fig. 2).
To isolate the potential influence of H3 and H4 receptors, thioperamide (1 µM) was added to tissues 
pre-treated with pyrilamine (30 nM) and cimetidine (1 µM, n = 8). Responses to histamine (100 µM) in the pres-
ence of thioperamide (1 µM) exhibited a small but observable increase in baseline tension, however, this increase 
was not significant.
Influence of selective histamine receptor antagonists on the detrusor. In the presence of 30 nM 
pyrilamine (H1 antagonist), responses to histamine (100 µM) were significantly inhibited in comparison to the 
control tissues (n = 8, p < 0.05, Table 2, Fig. 3). In the presence of 1 µM cimetidine (H2 antagonist, n = 8) and 
1 µM thioperamide (H3/H4 blocker, n = 4) no significant differences between the control and experimental tis-
sues were observed (Table 2, Fig. 3). The addition of the alternative H1-selective antagonist fexofenadine (1 µM, 
Antagonist Conc.
ΔTension (g) ΔFrequency (cpm)
nAbsence Presence Absence Presence
Pyrilamine 30 nM 0.97 ± 0.25 0.17 ± 0.11* 1.67 ± 0.26 0.24 ± 0.22** 8
Cimetidine 1 μM 0.81 ± 0.25 1.28 ± 0.38* 1.20 ± 0.65 1.27 ± 1.08 8
Thioperamide 1 μM 1.20 ± 0.29 1.75 ± 0.29* 1.49 ± 0.63 1.76 ± 0.55 6
Cyproheptadine 30 nM 1.19 ± 0.38 0.42 ± 0.16* 1.87 ± 0.78 0.56 ± 0.28* 8
Fexofenadine 1 μM 0.89 ± 0.24 −0.03 ± 0.02** 1.11 ± 0.28 −0.09 ± 0.14* 8
Table 1. U&LP responses to histamine (100 µM) in the presence of histamine receptor antagonists (mean 
change ± SEM). *p < 0.05, **p < 0.01. Paired Student’s t-test.
Figure 2. U&LP responses to histamine (100 µM) in the presence of more than one histamine receptor 
antagonist. **p < 0.001.
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n = 8) and cyproheptadine (30 nM, n = 8) showed inhibited contractile responses to histamine (p < 0.005, Table 2, 
Fig. 3).
Discussion
Data obtained in this study has provided several novel findings to aid in our understanding of histamine’s influ-
ence on bladder contractility. There are four main findings. (1) Histamine causes an increase in baseline tension 
in both the U&LP and detrusor layers. (2) In U&LP, histamine not only increases the baseline tension but also 
influences the frequency and amplitude of spontaneous phasic contractions observed in the U&LP tissue. (3) 
Activation of muscarinic receptors, as suggested in previous literature25, is not involved in the contractile response 
to histamine. 4) H2 receptor activation stimulates relaxation of U&LP in response to histamine.
This study focused on the role of histamine receptors on the U&LP and detrusor, two distinct layers of the 
bladder. Previous research has identified increased mast cells within the lamina propria layers of those suffering 
from overactive bladder15. It is possible that degranulates from these infiltrating mast cells could be causing the 
observed inflammation via the release of inflammatory mediators such as histamine and prostaglandins27. In 
addition to mast cells, there are other immune cells of the body that are also capable of releasing histamine, such 
as basophils and neutrophils at sites of inflammation. Furthermore, biopsies of patients suffering from OAB have 
demonstrated clear evidence of chronic inflammation17,28 in histological samples. Previously, functional studies 
have shown that histamine is capable of causing contractions in human detrusor strips29, guinea pig bladder21–23 
and rabbit detrusor24. However, our study is the first to identify and compare the responses to histamine in two 
distinct layers of the bladder that differ in structure and function: U&LP and detrusor. U&LP is comprised of sev-
eral layers of epithelial cells (urothelium) that line the lumen of the bladder and the underlying connective tissue 
layer (lamina propria), whereas detrusor is made of smooth muscle cells.
It was determined that in the presence of the H1 antagonist pyrilamine, increases in baseline tension in 
response to histamine were significantly inhibited in both U&LP and detrusor preparations. This is consistent 
with past studies showing pyrilamine’s effectiveness in inhibiting contractions to histamine in rabbit detrusor 
tissue30 and cultured human detrusor cells20. It is known that U&LP is capable of developing spontaneous phasic 
contractions in absence of any stimulation1. Significant increases in these contractions were observed when tis-
sues were treated with a single dose of histamine in the absence of any antagonists. However, when H1 receptor 
was blocked, the frequency of spontaneous phasic contractions did not increase. That indicates that H1 receptor 
not only is responsible for mediating the changes in baseline tension, but also in frequency of spontaneous phasic 
contractions in response to histamine. To further isolate the role of H1 in mediating contractions, combinations 
of antagonists were used. Whenever an H1 antagonist was present in the antagonist combination, increases in 
baseline tension in response to histamine were significantly inhibited. These findings ascertain the involvement of 
the H1 receptor in mediating contractions in the presence of histamine and further the conclusions from previous 
studies that present the involvement of H1 receptor in the mediation of bladder contractile responses21,22.
Antagonist Conc.
ΔTension (g)
nAbsence Presence
Pyrilamine 30 nM 0.98 ± 0.30 0.27 ± 0.12* 8
Cimetidine 1 μM 0.63 ± 0.17 0.29 ± 0.08 8
Thioperamide 1 μM 0.38 ± 0.12 0.27 ± 0.07 4
Cyproheptadine 30 nM 0.62 ± 0.21 0.07 ± 0.03* 8
Fexofenadine 1 μM 0.47 ± 0.05 0.08 ± 0.04* 8
Table 2. Detrusor responses to histamine (100 µM) in the presence of histamine receptor antagonists (mean 
change ± SEM). *p < 0.05. Paired Student’s t-test.
Figure 3. Detrusor responses to histamine (100 µM) as a control (left) and in the presence of pyrilamine (right, 
30 nM).
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The role of the H2 receptor was established through agonist and antagonist studies. When tissues were treated 
with amthamine, which is a potent and highly selective H2 agonist, a relaxation of baseline tension was observed 
in U&LP samples, but not in detrusor preparations. The addition of an H2 antagonist, cimetidine, caused 
increases in baseline tension in U&LP, however had no effect on the frequency of spontaneous phasic contrac-
tions. The lack of responses to either the H2 antagonist cimetidine or agonist amthamine in detrusor preparation 
indicates that the H2 receptor subtype, even though present in the tissue, is not involved in detrusor contractions.
When the combined H3 and H4 receptor antagonist thioperamide was added to the U&LP, increases in base-
line tension in response to histamine were observed. This increase in baseline tension most likely occurred due 
to the antagonist having an affinity for the other receptor subtypes present in the tissue. This was supported by 
experiments involving several antagonists. When U&LP was treated with all four receptor antagonists, the same 
small increase in baseline tension was observed, indicating that H3 and H4 receptors had no role in mediating 
the increase in tension. Previous literature suggests that increases in baseline tension to histamine, may be due 
a subsequent release of acetylcholine, acting on muscarinic receptors25 rather than an influence of histamine 
itself. However, the lack of any inhibition from atropine to the histamine response or receptor antagonism in this 
study suggests no involvement of muscarinic receptors. Any small increases in baseline tension observed in the 
presence of the H1 antagonist pyrilamine, are likely due to incomplete antagonism, as the concentrations were 
relatively small.
There were several differences between U&LP and detrusor tissue in response to histamine. It was determined 
that H1 and H2 receptors were only functional in U&LP tissue. Even though western blot analysis has shown 
all four histamine receptor subtypes present in the detrusor20, solely H1 was functional, and contractions were 
mediated by H1 receptors in both tissues. As epithelial cells of the urothelium have no contractile properties, the 
cells most likely involved in the contraction observed in organ bath experiments from U&LP tissue strips are the 
myofibroblasts or muscularis mucosa cells found in the lamina propria. Given the size and distribution of these 
cells within the connective tissue, they stimulate a strong contraction.
Conclusions
Histamine influences the contractile activity of both U&LP and detrusor of the porcine urinary bladder. It was 
determined that stimulation of the H1 receptor results in contractions in both urothelium with lamina propria 
and detrusor tissue samples. Activation of the H2 receptor inhibits the H1-mediated contractions in the urothe-
lium with lamina propria but not the detrusor, with H3 and H4 receptors having no functional role in bladder 
contractility. This study presents the H1 and H2 receptors as potential targets for future treatments for overactive 
bladder and other bladder contractile disorders.
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